ANZ has criticised the ACCCâs objection to its planned $4.9 billion merger with Suncorp, arguing before a tribunal that the alleged “uncertain” effects on competition in banking was not a sufficient reason to block the deal.
‘Serious and systemic’ failures in Australian Clinical Labs’ cyber framework left the pathology services provider vulnerable to a cyberattack that exposed the sensitive health data of more than 223,000 people, including tests for fertility and sexually transmitted diseases, according to the OAIC.
The Australian arm of global CEO advisory firm Teneo has rejected claims in a lawsuit by the former head of the company’s APAC talent advisory division that it forced her to work unreasonable hours and says it fired her for “serious and wilful” misconduct.
A judge has allowed Care A2 Plus to proceed with an appeal arguing a US lawsuit by former business partner Gensco should be blocked, saying the infant formula company will otherwise face a ârisk of substantial injusticeâ.Â
A nose job patient who allegedly defamed his surgeon has been hit with indemnity costs after refusing the surgeonâs âexceptionally generousâ offer to settle.
A talent scout whose company was acquired by Teneo is suing the Australian arm of the global CEO advisory firm, alleging she endured 16-hour workdays and was exposed to a toxic, male-dominated work culture.
The corporate regulator has again initiated proceedings against Gold Coast-based BHF Solutions and Cigno for allegedly providing credit without a licence after the lenders failed to convince the Full Court that their services fell outside the scope of the Credit Act.
The rancour is rising between Care A2 Plus and its US business partner Gensco Pharma, with the infant formula company firing off a cross-claim in a lawsuit alleging it breached a lucrative distribution deal.
The maker of Mother Energy drinks has failed to convince the High Court that it should weigh in on its long-running intellectual property spat with Vittoria Coffee, which ended in the removal of its ‘Motherland’ trade mark.
Infant formula giant Care A2 will try again to block business partner Gensco from bringing claims against it in a US court that overlap with a $200 million Australian lawsuit over a deal to sell formula in the US.